History of health technology assessment in Hungary

Gulàcsi, László; Brodszky, Valentin; Péntek, Márta; Varga, Siniša; Vas, G; Boncz, I

doi:10.1017/s0266462309090527

Cited by 30 publications

(37 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus alongside the growing body of actual practice data with biologicals there is an increasing need to use registry data in costeffectiveness analyses that reinforces their value. Moreover, the demand for health technology assessments (HTA) based on local data is getting higher and higher (18)(19)(20)(21)(22).…”

Section: Discussionmentioning

confidence: 99%

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

et al. 2014

View full text Add to dashboard Cite

Objective: The aim of this study was to evaluate efficacy, reasons for switching and drug survival of TNF-α inhibitors (TNFi-s) used as first and second line drugs in ankylosing spondylitis (AS).Methods: Data of patients suffering from AS and treated with at least one TNFi between November 2005 and November 2013 were extracted retrospectively from the database of one clinical center. Beside demographic data, the disease activity measured by BASDAI, the response rates (BASDAI50), reasons for switching and survival curves of TNFi-s were analyzed in general and in subgroups of patients treated with each of the available TNFi-s. The reasons for switching were defined as inefficacy, side effect of the given drug, patient's request, and occurence of extra-articular manifestations.Results: Altogether 175 patients were on TNFi and 77 of them received at least 2 TNFi-s. The patients' age at the initiation of the first TNFi was higher among switchers compared to nonswitchers (42.5±12.6 vs 38.8±11.2 years, p=0.049), otherwise gender, disease duration and initial disease activity had no influence on the risk of switching. The decrease of BASDAI was similar among non-switchers and switchers either using the first or second TNFi, but the response rates to the first and second TNFi were worse in switchers than in non-switchers. Following the failure of first TNFi, the retention on therapy was unfavourable, especially in patients on infliximab after one year of treatment. The main reason for switching from the first drug was inefficacy. The frequency of side effects that led to switching was higher in the infliximab group than in patiets treated with other agents. Conclusion:Although the retention rate to a second line TNFi was somewhat worse than that to the first line TNFi, switching of TNFi-s is a good therapeutic option is AS patients who failed to respond to the first TNFi.

show abstract

Section: Discussionmentioning

confidence: 99%

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Technical staff within National Technology Assessment Office of the National Institute for Strategic Health Research90…”

Section: Tablementioning

confidence: 99%

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Stafinski¹

2011

CEOR

View full text Add to dashboard Cite

Background:The purpose of this study was to compare centralized reimbursement/coverage decision-making processes for health technologies in 23 European countries, according to: mandate, authority, structure, and policy options; mechanisms for identifying, selecting, and evaluating technologies; clinical and economic evidence expectations; committee composition, procedures, and factors considered; available conditional reimbursement options for promising new technologies; and the manufacturers’ roles in the process.Methods:A comprehensive review of publicly available information from peer-reviewed literature (using a variety of bibliographic databases) and gray literature (eg, working papers, committee reports, presentations, and government documents) was conducted. Policy experts in each of the 23 countries were also contacted. All information collected was reviewed by two independent researchers.Results:Most European countries have established centralized reimbursement systems for making decisions on health technologies. However, the scope of technologies considered, as well as processes for identifying, selecting, and reviewing them varies. All systems include an assessment of clinical evidence, compiled in accordance with their own guidelines or internationally recognized published ones. In addition, most systems require an economic evaluation. The quality of such information is typically assessed by content and methodological experts. Committees responsible for formulating recommendations or decisions are multidisciplinary. While criteria used by committees appear transparent, how they are operationalized during deliberations remains unclear. Increasingly, reimbursement systems are expressing interest in and/or implementing reimbursement policy options that extend beyond the traditional “yes,” “no,” or “yes with restrictions” options. Such options typically require greater involvement of manufacturers which, to date, has been limited.Conclusion:Centralized reimbursement systems have become an important policy tool in many European countries. Nevertheless, there remains a lack of transparency around critical elements, such as how multiple factors or criteria are weighed during committee deliberations.

show abstract

“…Az egészség-ügyi ellátórendszerben tapasztalható negatívumok az orvostársadalom körében is tetten érhetők. Ennek okán e szakmacsoport körében is csökkenhet a szakmai megelé-gedettség mértéke, amely elővetítheti a külföldi munkavállalási magatartás felerősödését [5][6][7][8].…”

Section: Eredeti Közleményunclassified

Külföldi munkavállalás és pályaelhagyási indítékok a magyar gyógytornászok körében

et al. 2016

View full text Add to dashboard Cite

Pécsi Tudományegyetem, Klinikai Központ, PécsBevezetés: A magyar egészségügyi szférában munkát vállaló szakdolgozók körében növekvő tendenciát mutat a külföl-di munkavállalás. Célkitűzés: A szerzők célja a magyar gyógytornászok migrációs és pályaelhagyási magatartásának, illetve a hátterében lévő főbb kiváltó tényezők bemutatása. Módszer: 2014. áprilistól augusztusig országos felmérést végeztek a Magyarországon munkát vállaló gyógytornászok körében. Összesen 215 fő vett részt a felmérésben. Eredmények: Az eredmények szerint az életkor (p<0,05), illetve a munkahelyen tapasztalható anyagi megbecsülés mértéke (p<0,01) számottevő hatást gyakorol a migrációs gondolatok megjelenésére. Azon gyógytornászok, akik nem érzik anyagilag megbecsültnek magukat, több mint 55-szörös eséllyel vállalhatnak munkát az országhatáron kívül (OR = 55,28, CI [95%] = 18,85-162,12). Ennek hátterében lévő leggyakoribb okok az anyagi és erkölcsi megbecsüléssel kapcsolatos elégedetlenség (p<0,01) mindkét esetben). Következtetések: Annak érdekében, hogy megelőzzük a szakképzett gyógytornászok külföldi munkavállalását, illetve pályaelhagyását, szükséges növelni az anyagi és erkölcsi megbecsülés mértékét a magyar egészségügyi ellátórendszerben. Orv. Hetil., 2016, 157(9), 342-349.Kulcsszavak: egészségpolitika, humán erőforrás, migráció, pályaelhagyás, gyógytornász Motivations of foreign employment and carrier change among Hungarian physiotherapistsIntroduction: An increasing motivation can be experienced among professional workers within the Hungarian healthcare system towards foreign employment or career change. Aim: The aim of the authors was to assess Hungarian physiotherapists' migration and career changing behaviour and to understand the underlying factors. Method: A national survey in Hungary from April to August, 2014 was performed. Only physiotherapists who practice in Hungary were included (n = 215). Results: The results suggest that age (p<0.05) and the rate of financial appreciation experienced in the workplace (p<0.01) significantly affect the appearance of migratory thoughts. Those physiotherapists who do not feel themselves financially appreciated, are 55 times more likely to search for employment outside the country's borders [OR = 55.28 CI (95%) = 18.85 to 161.12]. The most common causes for that are unfavourable financial (p<0.01) and moral recognition (p<0.01). Conclusions: In order to prevent our already highly-qualified colleagues from leaving the country or from considering to leave the profession we should concentrate on increasing the financial and moral appreciation of the profession within the Hungarian healthcare system.

show abstract

History of health technology assessment in Hungary

Cited by 30 publications

References 14 publications

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Külföldi munkavállalás és pályaelhagyási indítékok a magyar gyógytornászok körében

Contact Info

Product

Resources

About